Clinical Trials Directory

Trials / Unknown

UnknownNCT05143268

Acupuncture for Dysphagia in Head and Neck Squamous Cell Carcinoma

Impact of Acupuncture on Acute Dysphagia in Patients Treated With Radio-chemotherapy for Head and Neck Squamous Cell Carcinoma: a Randomized Phase 2 Study

Status
Unknown
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
Lorenzo Livi · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a randomized phase 2 study on the impact of acupuncture on acute dysphagia in patients treated with radio-chemotherapy for head and neck squamous cell carcinoma

Detailed description

In order to attempt to reduce the impact of adverse effects produced by oncological treatments, cancer patients frequently turn to complementary integrative therapies. Among them, acupuncture has been characterized by a growing role in cancer-related symptoms management in last 10 years. After FDA approval for use as a medical device in 1996, the application of this technique in oncology has been on the rise in the Western countries. By modulating brain regions involved in cognition and emotion, some degree of successful symptom management with acupuncture has been demonstrated in oncology In the context of head and neck cancer, the first application of acupuncture was related to chronic shoulder pain and dysfunction following neck dissection. The primary objective of the study is to compare the effect of acupuncture and standard treatment on swallowing function assessed with MDADI scale (MD Anderson Dysphagia Inventory) 2 weeks after the end of RT (end of treatment, EoT).

Conditions

Timeline

Start date
2021-06-03
Primary completion
2023-10-30
Completion
2023-10-30
First posted
2021-12-03
Last updated
2022-11-10

Locations

2 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT05143268. Inclusion in this directory is not an endorsement.

Acupuncture for Dysphagia in Head and Neck Squamous Cell Carcinoma (NCT05143268) · Clinical Trials Directory